Abstract

Astrocytic glutamate transporter excitatory amino acid transporter (EAAT) 1, also known as glutamate aspartate transporter (GLAST) in rodents, is one of two glial glutamate transporters that are responsible for removing excess glutamate from synaptic clefts to prevent excitotoxic neuronal death. Despite its important role in neurophysiological functions, the molecular mechanisms of EAAT1 regulation at the transcriptional level remain to be established. Here, we report that NF-κB is a main positive transcription factor for EAAT1, supported by the following: 1) EAAT1 contains two consensus sites for NF-κB, 2) mutation of NF-κB binding sites decreased EAAT1 promoter activity, and 3) activation of NF-κB increased, whereas inhibition of NF-κB decreased EAAT1 promoter activity and mRNA/protein levels. EGF increased EAAT1 mRNA/protein levels and glutamate uptake via NF-κB. The transcription factor yin yang 1 (YY1) plays a role as a critical negative regulator of EAAT1, supported by the following: 1) the EAAT1 promoter contains multiple consensus sites for YY1, 2) overexpression of YY1 decreased EAAT1 promoter activity and mRNA/protein levels, and 3) knockdown of YY1 increased EAAT1 promoter activity and mRNA/protein levels. Manganese decreased EAAT1 expression via YY1. Epigenetic modifiers histone deacetylases (HDACs) served as co-repressors of YY1 to further decrease EAAT1 promoter activity, whereas inhibition of HDACs reversed manganese-induced decrease of EAAT1 expression. Taken together, our findings suggest that NF-κB is a critical positive regulator of EAAT1, mediating the stimulatory effects of EGF, whereas YY1 is a negative regulator of EAAT1 with HDACs as co-repressors, mediating the inhibitory effects of manganese on EAAT1 regulation.

Highlights

  • The mechanism for transcriptional regulation of EAAT1 remains to be elucidated

  • NF-␬B plays a critical role in enhancing EAAT1 expression induced by EGF and raloxifene in both rat and human astrocytes [19, 21], whereas Yin Yang 1 (YY1) plays an important role in reduction of EAAT1 mRNA levels in chick astrocytes [30]

  • Our findings demonstrate that NF-␬B is a major positive regulator of EAAT1, mediating the stimulatory effects of the positive modulator EGF on EAAT1 expression by the canonical activation of the NF-␬B pathway and induction of NF-␬B binding to the EAAT1 promoter (Figs. 1– 4)

Read more

Summary

Background

The mechanism for transcriptional regulation of EAAT1 remains to be elucidated. Results: EGF-activated NF-␬B is a positive regulator of EAAT1, whereas manganese-activated YY1, with HDACs acting as co-repressors, is a negative regulator. The same group showed that the anti-epileptic drug valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, increases EAAT1 promoter activity, mRNA/protein levels, and uptake activity in chick Bergmann glia cells while decreasing YY1 binding to the EAAT1 promoter [29], indicating a role for YY1 in repressing EAAT1. Because impaired EAAT1 function directly leads to glutamate excitotoxic neuronal injury associated with numerous neurological disorders, inhibition of HDACs is likely exerting neuroprotective effects through enhanced EAAT1 function via inhibition of transcriptional activities of genes regulated by HDACs. In the present study, we investigated the mechanism of positive as well as negative regulation of EAAT1 using EGF as a stimulator and manganese as a repressor at the transcriptional level in rat primary astrocytes and human astrocytic H4 cells. Our results establish that NF-␬B is a key positive regulator in mediating the stimulatory effects of EGF, whereas YY1 is a critical negative regulator in mediating the inhibitory effects of manganese on EAAT1 expression

Experimental Procedures
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.